3D Medicines
At 3D Medicines, they use individual’s genetic information to prevent, diagnose, and treat cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
$931m (Public information from Dec 2022)
Minhang District China (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
CNY670m | Late VC | ||
$40.1m | Early VC | ||
$224m | Late VC | ||
* | N/A | HKD251m Valuation: HKD7.7b | IPO |
| Total Funding | $356m | ||
Related Content
Recent News about 3D Medicines
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.